In response to the continued spread of the virus and the Federal and Bavarian government measures to limit contact among the public, the TUM Board of Management decided to extend the university’s restricted operations, for the time being, until 17 April 2020 at midnight. Current regulations will continue to apply for all TUM locations. For the most recent information on restrictions, please refer to the information at www.tum.de/en/corona.
New research results or upcoming events: Stay up-to-date on what is happening at TUM.
When it comes to corona testing capacity, as of now the Straubing Hospital is able to rely on support from the TUM campus. Campus laboratories began on Tuesday to analyze coronavirus samples. Staff are to start by testing 80 samples per day. The number of assessments is set for a big increase soon through the optimization of processes.
For the time being the corona pandemic has made it impossible to hold courses in lecture halls and seminar rooms. Nevertheless TUM wants to make sure that its 43,000 students suffer no serious consequences and they will still be able to continue their studies in the upcoming summer semester without extraordinary limitations. TUM President Thomas F. Hofmann is asking for support in order to implement a massive expansion of digital teaching.
The university hospital is participating in studies on new medications for people suffering from Covid-19. As part of a clinical study, patients can be treated with medications that are still under development. 50 patients infected with the novel Coronavirus are currently being treated at the university hospital TUM Klinikum rechts der Isar.
In 2013, the Stiftung Warentest found harmful benzene in drinks with cherry flavor. But how did the substance get into the drinks? Was the source benzaldehyde, an essential component of the cherry flavoring? And if so, how could the problem be solved? A new study by the Leibniz-Institute for Food Systems Biology and the Technical University of Munich (TUM) is now able to answer these questions.
At the recommendation of the TUM Corona Crisis Task Force, the TUM Board of Management has ordered the Technical University of Munich to place its operations under tight restrictions as of 6 pm on 18 March 2020. This decision was made in the interests of taking all reasonable measures to slow the spread of the coronavirus in accordance with the policy of the Bavarian state government. It is not yet foreseeable how long the restricted operations will remain in effect. However, we assume that this situation will continue until at least 31 March 2020.
During a viral infection, viruses enter the body and multiply in its cells. Viruses often specifically attach themselves to the sugar structures of the host cells, or present characteristic sugar structures on their surface themselves. Researchers at the Technical University of Munich (TUM) have developed a new type of protein reagent for identifying biological sugar structures, which may block the spread of an illness in the body if used for blocking the sugar structures of a cell or a pathogen.
Diseases of the brain are often associated with typical vascular changes. Now, scientists at LMU University Hospital Munich, Helmholtz Zentrum München and at the Technical University of Munich (TUM) have come up with a technique for visualising the structures of all the brain's blood vessels – right down to the finest capillaries – including any pathological changes. So far, they have used the technique, which is based on a combination of biochemical methods and artificial intelligence, to capture the whole brain vasculature of a mouse.
Plants are essential for life on earth. They provide food for essentially all organisms, oxygen for breathing, and they regulate the climate of the planet. Proteins play a key role in controlling all aspects of life including plants. Under the leadership of the Technical University of Munich (TUM), a team of scientists has now mapped around 18,000 of all the proteins found in the model plant Arabidopsis thaliana.
Bone marrow plasma cells produce antibodies. These comprise two long and two short protein chains. The pathological proliferation of plasma cells can lead to an overproduction of the short chains. These associate to fibrils and deposit in organs. The result is fatal organ failure. A research team from the Technical University of Munich (TUM) and Heidelberg University has now identified the mutation behind the disease in a patient.
One drone, four microphones and a loudspeaker: nothing more is needed to determine the position of walls and other flat surfaces within a room. This has been mathematically proved by Prof. Gregor Kemper of the Technical University of Munich and Prof. Mireille Boutin of Purdue University in Indiana, USA.